Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Caballero JC, Dávila J, López-Pavía M, Such E, Bernal T, Ramos F, Calabuig M, Hernández Sánchez JM, Pomares H, Sánchez Barba M, Abáigar M, González B, Merchán B, Sancho-Tello R, Callejas M, Muñoz-Novas C, Cerveró C, Sanz G, Hernández Rivas JM, Díez Campelo M. Caballero JC, et al. Among authors: hernandez sanchez jm. Ther Adv Hematol. 2024 Jan 4;15:20406207231218157. doi: 10.1177/20406207231218157. eCollection 2024. Ther Adv Hematol. 2024. PMID: 38186638 Free PMC article.
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Caballero JC, Sánchez Barba M, Hernández Sánchez JM, Such E, Janusz K, Sanz G, Cabrero M, Chillón C, Cervera J, Hurtado AM, Jerez A, Calderón Cabrera C, Valcárcel D, Lumbreras E, Abáigar M, López Cadenas F, Hernández Rivas JM, Del Cañizo MC, Díez Campelo M. Caballero JC, et al. Among authors: sanchez barba m, hernandez sanchez jm, hernandez rivas jm. Ann Hematol. 2019 Sep;98(9):2151-2162. doi: 10.1007/s00277-019-03751-6. Epub 2019 Jul 16. Ann Hematol. 2019. PMID: 31312927
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Palomo L, Ibáñez M, Abáigar M, Vázquez I, Álvarez S, Cabezón M, Tazón-Vega B, Rapado I, Fuster-Tormo F, Cervera J, Benito R, Larrayoz MJ, Cigudosa JC, Zamora L, Valcárcel D, Cedena MT, Acha P, Hernández-Sánchez JM, Fernández-Mercado M, Sanz G, Hernández-Rivas JM, Calasanz MJ, Solé F, Such E; Spanish Group of MDS (GESMD). Palomo L, et al. Among authors: hernandez sanchez jm, hernandez rivas jm. Br J Haematol. 2020 Mar;188(5):605-622. doi: 10.1111/bjh.16175. Epub 2019 Oct 16. Br J Haematol. 2020. PMID: 31621063 Free PMC article.
Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
Martín-Izquierdo M, Abáigar M, Hernández-Sánchez JM, Tamborero D, López-Cadenas F, Ramos F, Lumbreras E, Madinaveitia-Ochoa A, Megido M, Labrador J, Sánchez-Real J, Olivier C, Dávila J, Aguilar C, Rodríguez JN, Martín-Nuñez G, Santos-Mínguez S, Miguel-García C, Benito R, Díez-Campelo M, Hernández-Rivas JM. Martín-Izquierdo M, et al. Among authors: hernandez sanchez jm. Haematologica. 2021 Aug 1;106(8):2215-2223. doi: 10.3324/haematol.2020.248807. Haematologica. 2021. PMID: 32675227 Free PMC article.
Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology.
Bastida JM, López-Godino O, Vicente-Sánchez A, Bonanad-Boix S, Xicoy-Cirici B, Hernández-Sánchez JM, Such E, Cervera J, Caballero-Berrocal JC, López-Cadenas F, Arnao-Herráiz M, Rodríguez I, Llopis-Calatayud I, Jiménez MJ, Del Cañizo-Roldán MC, Díez-Campelo M. Bastida JM, et al. Among authors: hernandez sanchez jm. Int J Lab Hematol. 2019 Feb;41(1):109-117. doi: 10.1111/ijlh.12933. Epub 2018 Oct 5. Int J Lab Hematol. 2019. PMID: 30290085
Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia.
Sanchez-Garcia J, Falantes J, Medina Perez A, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Solé Rodriguez M, Casaño FJ, Calderon C, Labrador M, Vahí M, Serrano J, Lumbreras E, Hernández-Rivas JM; Grupo Andaluz SMD. Sanchez-Garcia J, et al. Among authors: hernandez sanchez jm, hernandez rivas jm, hernandez mohedo f. Leuk Lymphoma. 2018 May;59(5):1095-1104. doi: 10.1080/10428194.2017.1366998. Epub 2017 Aug 24. Leuk Lymphoma. 2018. PMID: 28836866 Clinical Trial.
DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains.
Hernández-Sánchez M, Rodríguez-Vicente AE, González-Gascón Y Marín I, Quijada-Álamo M, Hernández-Sánchez JM, Martín-Izquierdo M, Hernández-Rivas JÁ, Benito R, Hernández-Rivas JM. Hernández-Sánchez M, et al. Among authors: hernandez rivas ja, hernandez sanchez jm, hernandez rivas jm. Exp Hematol. 2019 Apr;72:9-13. doi: 10.1016/j.exphem.2019.02.003. Epub 2019 Feb 23. Exp Hematol. 2019. PMID: 30807786 Free article.
Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag.
Hernández-Sánchez JM, Bastida JM, Alonso-López D, Benito R, González-Porras JR, De Las Rivas J, Hernández Rivas JM, Rodríguez-Vicente AE. Hernández-Sánchez JM, et al. Among authors: hernandez rivas jm. Platelets. 2020 Nov 16;31(8):993-1000. doi: 10.1080/09537104.2019.1702156. Epub 2019 Dec 14. Platelets. 2020. PMID: 31838946
Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide.
Adema V, Palomo L, Toma A, Kosmider O, Fuster-Tormo F, Benito R, Salgado R, Such E, Larrayoz MJ, Xicoy B, Hernandez-Sanchez JM, Maietta P, Neef A, Fontenay M, Ibañez M, Diez-Campelo M, Alvarez S, Maciejewski JP, Fenaux P, Sole F. Adema V, et al. Among authors: hernandez sanchez jm. Br J Haematol. 2020 May;189(4):e133-e137. doi: 10.1111/bjh.16558. Epub 2020 Mar 9. Br J Haematol. 2020. PMID: 32147816 Free PMC article. No abstract available.
FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia.
Dubuc AM, Davids MS, Pulluqi M, Pulluqi O, Hoang K, Hernandez-Sánchez JM, Schlich C, Hernández-Rivas JM, Brown JR, Dal Cin P. Dubuc AM, et al. Among authors: hernandez sanchez jm, hernandez rivas jm. Am J Hematol. 2016 Oct;91(10):978-83. doi: 10.1002/ajh.24452. Epub 2016 Jul 22. Am J Hematol. 2016. PMID: 27341486 Free article.
45 results